[DPHARMA] QoQ Cumulative Quarter Result on 30-Sep-2021 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
18-Nov-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2021
Quarter
30-Sep-2021 [#3]
Profit Trend
QoQ- 51.4%
YoY- 17.8%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 367,683 185,941 639,175 493,731 321,893 166,454 569,902 -25.39%
PBT 48,119 26,646 82,983 65,856 43,373 23,176 76,157 -26.42%
Tax -11,517 -6,355 -17,300 -15,889 -10,369 -5,562 -17,547 -24.53%
NP 36,602 20,291 65,683 49,967 33,004 17,614 58,610 -27.00%
-
NP to SH 36,602 20,291 65,683 49,967 33,004 17,614 58,610 -27.00%
-
Tax Rate 23.93% 23.85% 20.85% 24.13% 23.91% 24.00% 23.04% -
Total Cost 331,081 165,650 573,492 443,764 288,889 148,840 511,292 -25.21%
-
Net Worth 634,375 621,987 621,564 612,147 614,350 635,424 642,484 -0.84%
Dividend
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Div 4,734 - 21,660 4,708 3,530 - 45,891 -78.09%
Div Payout % 12.93% - 32.98% 9.42% 10.70% - 78.30% -
Equity
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Net Worth 634,375 621,987 621,564 612,147 614,350 635,424 642,484 -0.84%
NOSH 952,239 941,765 941,765 941,765 706,330 706,026 706,026 22.13%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin 9.95% 10.91% 10.28% 10.12% 10.25% 10.58% 10.28% -
ROE 5.77% 3.26% 10.57% 8.16% 5.37% 2.77% 9.12% -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
RPS 38.83 20.03 67.87 52.43 45.58 23.58 80.72 -38.68%
EPS 3.88 2.19 6.98 5.31 4.67 2.49 8.46 -40.61%
DPS 0.50 0.00 2.30 0.50 0.50 0.00 6.50 -81.99%
NAPS 0.67 0.67 0.66 0.65 0.87 0.90 0.91 -18.50%
Adjusted Per Share Value based on latest NOSH - 941,765
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
RPS 38.22 19.33 66.45 51.33 33.46 17.30 59.24 -25.39%
EPS 3.81 2.11 6.83 5.19 3.43 1.83 6.09 -26.91%
DPS 0.49 0.00 2.25 0.49 0.37 0.00 4.77 -78.15%
NAPS 0.6595 0.6466 0.6462 0.6364 0.6387 0.6606 0.6679 -0.84%
Price Multiplier on Financial Quarter End Date
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Date 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 -
Price 1.20 1.49 1.68 1.81 3.03 2.75 3.38 -
P/RPS 3.09 7.44 2.48 3.45 6.65 11.66 4.19 -18.41%
P/EPS 31.04 68.17 24.09 34.11 64.83 110.23 40.72 -16.59%
EY 3.22 1.47 4.15 2.93 1.54 0.91 2.46 19.71%
DY 0.42 0.00 1.37 0.28 0.17 0.00 1.92 -63.79%
P/NAPS 1.79 2.22 2.55 2.78 3.48 3.06 3.71 -38.56%
Price Multiplier on Announcement Date
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Date 16/08/22 17/05/22 15/02/22 18/11/21 17/08/21 03/05/21 22/02/21 -
Price 1.34 1.51 1.60 1.62 2.49 2.93 3.42 -
P/RPS 3.45 7.54 2.36 3.09 5.46 12.43 4.24 -12.87%
P/EPS 34.66 69.08 22.94 30.53 53.28 117.44 41.20 -10.91%
EY 2.88 1.45 4.36 3.28 1.88 0.85 2.43 12.02%
DY 0.37 0.00 1.44 0.31 0.20 0.00 1.90 -66.50%
P/NAPS 2.00 2.25 2.42 2.49 2.86 3.26 3.76 -34.42%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment